A competitive ELISA for quantifying serum CD147: Reduction of soluble cd147 levels in cancer patient sera
CD147/EMMPRIN (extracellular matrix metalloproteinase inducer) is a cell surface glycoprotein that displays increased expression in many cancers. It has been previously demonstrated to participate in cancer metastasis and progression. In this study we used an anti-CD147 monoclonal antibody and a rec...
Saved in:
Main Authors: | Moonsom S., Tayapiwatana C., Wongkham S., Kongtawelert P., Kasinrerk W. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-77749270826&partnerID=40&md5=9aeff321cfc8d1bec5055034a680484d http://www.ncbi.nlm.nih.gov/pubmed/20199151 http://cmuir.cmu.ac.th/handle/6653943832/2622 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
A competitive ELISA for quantifying serum CD147: Reduction of soluble cd147 levels in cancer patient sera
by: Moonsom S., et al.
Published: (2014) -
A competitive ELISA for quantifying serum CD147: Reduction of soluble cd147 levels in cancer patient sera
by: Seangdeun Moonsom, et al.
Published: (2018) -
Antibody biosensors for the measurement and characterization of soluble CD147 molecules
by: Witida Laopajon, et al.
Published: (2018) -
Discovery of CD147 molecular function by phage-displayed CD147 ectodomain VIA gpVIII
by: Nutjeera Intasai
Published: (2023) -
Reduction of CD147 surface expression on primary T cells leads to enhanced cell proliferation
by: Biegler B., et al.
Published: (2015)